Jan 14, 2026 by Reuben Gregg BrewerTop Stocks to Double Up on Right NowInvestors are cautious about the future of this historically reliable sector, making it a potentially attractive buy for long-term investors.
Jan 14, 2026 by Selena Maranjian12 Top ETFs to Buy in January for Higher Passive Income in 2026 -- Including the Schwab U.S. Dividend Equity ETF (SCHD)Who wouldn't love to have streams of cash coming to them regularly?
Jan 14, 2026 by David Jagielski, CPAIs UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?The healthcare stock trades at a significantly reduced valuation after an abysmal performance last year.
Jan 14, 2026 by Keith NoonanWhy Broadcom Stock Sank TodayBroadcom stock got hit with multiple bearish catalysts today.
Jan 14, 2026 by Jennifer SaibilIs Opendoor Stock the Next 10-Bagger?The real estate innovator was (for a time) a five-bagger in 2025 before settling out at a 264% gain on the year.
Jan 14, 2026 by Micah ZimmermanThis Niche Tech Stock Dropped 50%, but Its Revenue Model Means It's Poised for a ComebackThis overlooked stock could claim market share in 2026.
Jan 14, 2026 by Reuben Gregg BrewerTop Stocks to Double Up on Right NowInvestors are cautious about the future of this historically reliable sector, making it a potentially attractive buy for long-term investors.
Jan 14, 2026 by James HiresAlphabet vs. OpenAI: Which AI Giant Will Drive 100% Gains?AI is big business, but can the start-up that made it mainstream stand up to an industry giant throwing its weight around?
Jan 14, 2026 by Lawrence NgaWhat Ferrari Needs to Prove in 2026Ferrari enters 2026 as one of the world's most admired luxury businesses -- but admiration alone won't move the stock.
Jan 14, 2026 by Eric TrieIEFA vs. SPDW: Broad International Exposure With Different Portfolio DesignsThe iShares Core MSCI EAFE ETF and the SPDR Portfolio Developed World ex‑US ETF may look similar on paper, but each offers a distinct approach to owning international stocks outside the U.S.
Jan 14, 2026 by Howard SmithWhy Did Rivian Stock Plunge Today?2026 will be a pivotal year for Rivian Automotive.
Jan 14, 2026 by Keithen DruryIonQ's Biggest Advantage in Quantum Computing Could Be Its Biggest WeaknessIonQ's approach to quantum computing is different from that of its peers.
Jan 14, 2026 by Selena Maranjian12 Top ETFs to Buy in January for Higher Passive Income in 2026 -- Including the Schwab U.S. Dividend Equity ETF (SCHD)Who wouldn't love to have streams of cash coming to them regularly?
Jan 14, 2026 by Anders BylundWhy Duolingo Stock Lost 46% in 2025 (And What's Next)Duolingo's 2025 was a wild ride. A sky-high valuation came back to earth, but the growth story remains intact.
Jan 14, 2026 by Rich SmithWhy Voyager Technologies Stock Surged TodayVoyager just got its first great space business idea for once it has a space station.
Jan 14, 2026 by Marc GubertiIs This the Smartest Growth Stock to Buy Heading Into 2026?The biggest tech stock is still one of the smartest picks of 2026.
Jan 14, 2026 by Scott LevineWhy Critical Metals Stock Is Rocketing Higher TodayThis rare-earth stock is flying higher thanks to an encouraging announcement.
Jan 14, 2026 by David Jagielski, CPAIs UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?The healthcare stock trades at a significantly reduced valuation after an abysmal performance last year.
Jan 14, 2026 by Robert IzquierdoIs Revolve Group Stock a Buy or Sell After the Co-CEO Sold Shares for $6 Million?This e-commerce fashion retailer, known for its influencer-driven platforms, reported significant insider selling in its latest SEC filing.
Jan 14, 2026 by Katie BrockmanIf the Stock Market Crashes in 2026, There's 1 Vanguard ETF I'll Be Stocking Up OnThis ETF can help build long-term wealth while still protecting against volatility.
Jan 14, 2026 by Christy BieberMedicare Advantage Covers 3 Surprising Grocery Store StaplesMedicare Advantage plans may cover more than you think.
Jan 14, 2026 by David Jagielski, CPAEli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain ReliefRetatrutide is an exciting GLP-1 drug that has explosive potential.
Jan 14, 2026 by Robert IzquierdoIs Warby Parker Stock a Buy or Sell After the Co-CEO Sold Shares for $2.6 Million?Known for its direct-to-consumer eyewear, this omnichannel retailer reported significant insider selling in its latest SEC filing.
